HEADER TRANSCRIPTION 12-AUG-05 2AO6 TITLE CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN TITLE 2 BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANDROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: DIHYDROTESTOSTERONE RECEPTOR; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: INHIBITED BY R1881; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: 14-MER FRAGMENT OF NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: BOX 3, RESIDUES 740-753; COMPND 12 SYNONYM: NCOA-2; TRANSCRIPTIONAL INTERMEDIARY FACTOR 2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AR, NR3C4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 OTHER_DETAILS: HUMAN AR LBD (663-919) WITH THROMBIN CLEAVABLE NH2- SOURCE 12 TERMINAL HIS TAG; SOURCE 13 MOL_ID: 2; SOURCE 14 SYNTHETIC: YES; SOURCE 15 OTHER_DETAILS: 14-MER FRAGMENT OF TRANSCRIPTIONAL INTERMEDIARY SOURCE 16 FACTOR 2, RESIDUES 740-753 KEYWDS CRYSTAL STRUCTURE; HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN; KEYWDS 2 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2 740-753; R188, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR B.HE,R.T.GAMPE JR.,A.J.KOLE,A.T.HNAT,T.B.STANLEY,G.AN,E.L.STEWART, AUTHOR 2 R.I.KALMAN,J.T.MINGES,E.M.WILSON REVDAT 4 23-AUG-23 2AO6 1 REMARK SEQADV REVDAT 3 11-OCT-17 2AO6 1 REMARK REVDAT 2 24-FEB-09 2AO6 1 VERSN REVDAT 1 30-AUG-05 2AO6 0 SPRSDE 30-AUG-05 2AO6 1XQ2 JRNL AUTH B.HE,R.T.GAMPE JR.,A.J.KOLE,A.T.HNAT,T.B.STANLEY,G.AN, JRNL AUTH 2 E.L.STEWART,R.I.KALMAN,J.T.MINGES,E.M.WILSON JRNL TITL STRUCTURAL BASIS FOR ANDROGEN RECEPTOR INTERDOMAIN AND JRNL TITL 2 COACTIVATOR INTERACTIONS SUGGESTS A TRANSITION IN NUCLEAR JRNL TITL 3 RECEPTOR ACTIVATION FUNCTION DOMINANCE JRNL REF MOL.CELL V. 16 425 2004 JRNL REFN ISSN 1097-2765 JRNL PMID 15525515 JRNL DOI 10.1016/J.MOLCEL.2004.09.036 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 850450.640 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 19177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 560 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.89 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.99 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2264 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 63 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.042 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2013 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 152 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.270 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.260 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.230 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 57.04 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : R18_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: GROS, GROSSE-KUNSTLEVE, JIANG, REMARK 3 KUSZEWSKI, NILGES, PANNU, READ, RICE, SIMONSON, WARREN AND REMARK 3 MOLECULAR SIMULATIONS INC., (BADGER, BERARD, KUMAR, SZALMA, YIP). REMARK 4 REMARK 4 2AO6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000034120. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 93.0 REMARK 200 PH : 7.90 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20036 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 30.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.22700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2000 REMARK 200 STARTING MODEL: 1XOW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM BTP, 0.6 M NA/K TARTRATE, PH REMARK 280 7.90, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.29000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.70000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.70000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.29000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 844 REMARK 465 LYS A 845 REMARK 465 ARG A 846 REMARK 465 LYS A 847 REMARK 465 ASN A 848 REMARK 465 PRO A 849 REMARK 465 GLN A 919 REMARK 465 LYS B 727 REMARK 465 GLU B 728 REMARK 465 ASN B 729 REMARK 465 ALA B 730 REMARK 465 LEU B 731 REMARK 465 LEU B 732 REMARK 465 ARG B 733 REMARK 465 TYR B 734 REMARK 465 LEU B 735 REMARK 465 LEU B 736 REMARK 465 ASP B 737 REMARK 465 LYS B 738 REMARK 465 ASP B 739 REMARK 465 ASP B 740 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 678 CG CD OE1 OE2 REMARK 470 ARG A 760 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 816 CG1 CG2 CD1 REMARK 470 ASP A 819 CG OD1 OD2 REMARK 470 LYS A 822 CG CD CE NZ REMARK 470 LYS A 825 CG CD CE NZ REMARK 470 GLU A 829 CG CD OE1 OE2 REMARK 470 LYS A 836 CG CD CE NZ REMARK 470 SER A 851 OG REMARK 470 SER A 853 OG REMARK 470 ARG A 854 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 893 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 757 24.92 -142.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R18 A 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XOW RELATED DB: PDB REMARK 900 ANDROGEN RECEPTOR LBD BOUND WITH AR20-30 PEPTIDE AND R1881 REMARK 900 RELATED ID: 1XQ3 RELATED DB: PDB REMARK 900 ANDROGEN RECEPTOR LBD BOUND WITH R1881 AND NO PEPTIDE DBREF 2AO6 A 671 919 UNP P10275 ANDR_HUMAN 671 919 DBREF 2AO6 B 727 740 UNP Q15596 NCO2_HUMAN 740 753 SEQADV 2AO6 GLY B 741 UNP Q15596 INSERTION SEQADV 2AO6 ASN B 742 UNP Q15596 INSERTION SEQADV 2AO6 ALA B 743 UNP Q15596 INSERTION SEQADV 2AO6 ALA B 744 UNP Q15596 INSERTION SEQADV 2AO6 LEU B 745 UNP Q15596 INSERTION SEQADV 2AO6 ARG B 746 UNP Q15596 INSERTION SEQADV 2AO6 TYR B 747 UNP Q15596 INSERTION SEQADV 2AO6 LEU B 748 UNP Q15596 INSERTION SEQADV 2AO6 LEU B 749 UNP Q15596 INSERTION SEQADV 2AO6 GLY B 750 UNP Q15596 INSERTION SEQADV 2AO6 ALA B 751 UNP Q15596 INSERTION SEQRES 1 A 249 PRO ILE PHE LEU ASN VAL LEU GLU ALA ILE GLU PRO GLY SEQRES 2 A 249 VAL VAL CYS ALA GLY HIS ASP ASN ASN GLN PRO ASP SER SEQRES 3 A 249 PHE ALA ALA LEU LEU SER SER LEU ASN GLU LEU GLY GLU SEQRES 4 A 249 ARG GLN LEU VAL HIS VAL VAL LYS TRP ALA LYS ALA LEU SEQRES 5 A 249 PRO GLY PHE ARG ASN LEU HIS VAL ASP ASP GLN MET ALA SEQRES 6 A 249 VAL ILE GLN TYR SER TRP MET GLY LEU MET VAL PHE ALA SEQRES 7 A 249 MET GLY TRP ARG SER PHE THR ASN VAL ASN SER ARG MET SEQRES 8 A 249 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU TYR ARG SEQRES 9 A 249 MET HIS LYS SER ARG MET TYR SER GLN CYS VAL ARG MET SEQRES 10 A 249 ARG HIS LEU SER GLN GLU PHE GLY TRP LEU GLN ILE THR SEQRES 11 A 249 PRO GLN GLU PHE LEU CYS MET LYS ALA LEU LEU LEU PHE SEQRES 12 A 249 SER ILE ILE PRO VAL ASP GLY LEU LYS ASN GLN LYS PHE SEQRES 13 A 249 PHE ASP GLU LEU ARG MET ASN TYR ILE LYS GLU LEU ASP SEQRES 14 A 249 ARG ILE ILE ALA CYS LYS ARG LYS ASN PRO THR SER CYS SEQRES 15 A 249 SER ARG ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 16 A 249 VAL GLN PRO ILE ALA ARG GLU LEU HIS GLN PHE THR PHE SEQRES 17 A 249 ASP LEU LEU ILE LYS SER HIS MET VAL SER VAL ASP PHE SEQRES 18 A 249 PRO GLU MET MET ALA GLU ILE ILE SER VAL GLN VAL PRO SEQRES 19 A 249 LYS ILE LEU SER GLY LYS VAL LYS PRO ILE TYR PHE HIS SEQRES 20 A 249 THR GLN SEQRES 1 B 25 LYS GLU ASN ALA LEU LEU ARG TYR LEU LEU ASP LYS ASP SEQRES 2 B 25 ASP GLY ASN ALA ALA LEU ARG TYR LEU LEU GLY ALA HET R18 A1001 21 HETNAM R18 (17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE HETSYN R18 METHYLTRIENOLONE; 17BETA-HYDROXY-17METHYL- HETSYN 2 R18 19NORANDROSTA-4,9,11-TRIEN-3-ONE; R1881 FORMUL 3 R18 C19 H24 O2 FORMUL 4 HOH *152(H2 O) HELIX 1 1 PRO A 671 GLU A 681 1 11 HELIX 2 2 SER A 696 ALA A 721 1 26 HELIX 3 3 GLY A 724 LEU A 728 5 5 HELIX 4 4 HIS A 729 ASN A 758 1 30 HELIX 5 5 ASN A 771 SER A 778 1 8 HELIX 6 6 MET A 780 LEU A 797 1 18 HELIX 7 7 THR A 800 LEU A 812 1 13 HELIX 8 8 ASN A 823 ALA A 843 1 21 HELIX 9 9 THR A 850 SER A 888 1 39 HELIX 10 10 PRO A 892 GLN A 902 1 11 HELIX 11 11 GLN A 902 SER A 908 1 7 HELIX 12 12 ASN B 742 ALA B 751 1 10 SHEET 1 A 2 LEU A 762 ALA A 765 0 SHEET 2 A 2 LEU A 768 PHE A 770 -1 O PHE A 770 N LEU A 762 SHEET 1 B 2 ILE A 815 PRO A 817 0 SHEET 2 B 2 VAL A 911 PRO A 913 -1 O LYS A 912 N ILE A 816 SITE 1 AC1 10 LEU A 704 ASN A 705 GLN A 711 MET A 742 SITE 2 AC1 10 MET A 745 MET A 749 ARG A 752 PHE A 764 SITE 3 AC1 10 PHE A 876 THR A 877 CRYST1 54.580 66.700 69.400 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018322 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014993 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014409 0.00000